Switching between generics of anti-epileptic drugs

2017-03-29 Two different generic versions of anti-epilepsy medicine lamotrigine have been shown to be bioequivalent in patients with epilepsy and to not cause any differences in… Read More »

Monoclonal antibodies and the challenge of substitution

2017-03-27 Healthcare payers are eagerly awaiting the arrival of biosimilar competition in the innovative monoclonal antibody sector in order to drive down drug prices and increase… Read More »

South Korean pharma market to reach US$20 billion by 2020

2017-03-24 The pharmaceutical market in South Korea is on the increase and is expected to reach more than US$20 billion by 2020. According to a report… Read More »

Cost-effectiveness analysis and incentivizing innovation

2017-03-22 In the paper by Santiago Moreno and Joshua Ray, the controversial role that conventional cost-effectiveness analysis (CEA) plays in incentivizing innovation is revealed [1]. Detractors… Read More »

Is a new pathway for NBCDs on the way in the US?

2017-03-20 The US Food and Drug Administration (FDA) does not formerly recognize non-biological complex drugs (NBCDs), with originators required to follow the new drug application (NDA)… Read More »

Switching between different ESAs

2017-03-17 Switching between reference biologicals and biosimilars can be a contentious issue. A study from Italy, however, has found that this phenomenon is not limited to… Read More »

Japan proving to be a favourable market for biosimilars

2017-03-15 Uptake of biosimilars in Japan is on a par with generics use for some products, making Japan a lucrative market for biosimilars makers. In Japan,… Read More »

Perceptions of the value of generics in Brazil

2017-03-13 Generics were first approved in Brazil in 1999. Substitution of generics and reference drugs can occur at the time of purchase and upon patients’ request,… Read More »

Clinical and regulatory issues for biosimilars

2017-03-10 As the first biosimilars are being approved in the US, there are a number of clinical and regulatory issues that must be considered for the… Read More »

Perceptions of the effectiveness and quality of generics

2017-03-08 More than a quarter of doctors and the general public believe that generics are less effective and of poorer quality than brand-name drugs, according to… Read More »

Page 2 of 49 « Previous1 2 3 4 5 Next »... 49
Go Back Print